Reference

CMO(2022)21

Name

COVID-19 vaccination programme: JCVI advice on additional booster doses for clinical trial participants

Categories

Scottish Government CMO Letters

Organization

Scottish Government Health and Social Care Directorates

Keywords

NHS SCOTLAND COVID-19 CORONAVIRUS VACCINATION BOOSTER CLINICAL TRIALS JCVI

Description

This letter provides details of the Joint Committee on Vaccination and Immunisation (JCVI) recommendations relating to the administration of additional MHRA authorised COVID-19 booster doses to those participating in COVID-19 booster and sub-variant vaccination clinical trials, in order to mitigate issues linked to international travel and certification.

Contact Name

Contact Email

Contact Address

Contact Phone

Created

2022-05-18 00:00:00

Download URL